DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

References

Cabanillas ME, Schlumberger M, Jarzab B. et al.
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: a clinical outcomes and biomarker assessment.

Cancer 2015;
121 (16) 2749-2756

Download Bibliographical Data

Access:
Access: